Figure 2From: Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease Trough forced expiratory volume in 1 second for aclidinium 200 μg versus placebo over 52 weeks in ACCLAIM/COPD I and II Back to article page